Page 35 - GPD-2-3

Gene & Protein in Disease Signatures construction strategies for TC

https://doi.org/10.1159/000486422 prospective opportunities. Front Endocrinol (Lausanne),
14: 1101410.
7. Lupoli GA, Fonderico F, Colarusso S, et al., 2005, Current
management of differentiated thyroid carcinoma. Med Sci https://doi.org/10.3389/fendo.2023.1101410
Monit, 11(12): RA368–RA373. 19. Wu M, Yuan H, Li X, et al., 2019, Identification of a five-
8. Baloch ZW, Asa SL, Barletta JA, et al., 2022, Overview of gene signature and establishment of a prognostic nomogram
the 2022 WHO classification of thyroid neoplasms. Endocr to predict progression-free interval of papillary thyroid
Pathol, 33(1): 27–63. carcinoma. Front Endocrinol (Lausanne), 10: 790.
https://doi.org/10.1007/s12022-022-09707-3 https://doi.org/10.3389/fendo.2019.00790
9. Cabanillas ME, McFadden DG, Durante C, 2016, Thyroid 20. Ruiz EM, Niu T, Zerfaoui M, et al., 2020, A novel gene panel
cancer. Lancet, 388(10061): 2783–2795. for prediction of lymph-node metastasis and recurrence in
patients with thyroid cancer. Surgery, 167(1): 73–79.
https://doi.org/10.1016/S0140-6736(16)30172-6
https://doi.org/10.1016/j.surg.2019.06.058
10. Metovic J, Cabutti F, Osella-Abate S, et al., 2023, Clinical
and pathological features and gene expression profiles of 21. Teng H, Mao F, Liang J, et al., 2018, Transcriptomic
clinically aggressive papillary thyroid carcinomas. Endocr signature associated with carcinogenesis and aggressiveness
Pathol. of papillary thyroid carcinoma. Theranostics, 8(16):
4345–4358.
https://doi.org/10.1007/s12022-023-09769-x
https://doi.org/10.7150/thno.26862
11. Liu Z, Zhao Q, Zeng W, et al., 2018, Prognosis of a rare
subtype of thyroid cancer: Spindle cell thyroid carcinoma. 22. Hu G, Feng HF, Zhan H, 2020, Identification of an
Medicine (Baltimore), 97(45): e13053. autophagy-related signature predicting overall survival for
papillary thyroid carcinoma. Dose Response, 18(1).
https://doi.org/10.1097/MD.0000000000013053
https://doi.org/10.1177/1559325819899265
12. Soares P, Celestino R, Melo M, et al., 2014, Prognostic
biomarkers in thyroid cancer. Virchows Arch, 464(3): 23. Lin P, He Y, Wen DY, et al., 2018, Comprehensive analysis
333–346. of the clinical significance and prospective molecular
mechanisms of differentially expressed autophagy-related
https://doi.org/10.1007/s00428-013-1521-2 genes in thyroid cancer. Int J Oncol, 53(2): 603–619.
13. Yapa S, Mulla O, Green V, et al., 2017, The role of chemokines https://doi.org/10.3892/ijo.2018.4404
in thyroid carcinoma. Thyroid, 27(11): 1347–1359.
24. Lin P, Guo YN, Shi L, et al., 2019, Development of a
https://doi.org/10.1089/thy.2016.0660 prognostic index based on an immunogenomic landscape
14. Wolff L, Steindl A, Popov P, et al., 2023, Clinical analysis of papillary thyroid cancer. Aging (Albany NY),
characteristics, treatment, and long-term outcome of 11(2): 480–500.
patients with brain metastases from thyroid cancer. Clin Exp https://doi.org/10.18632/aging.101754
Metastasis, 40(3): 217–226.
25. Qin R, Li C, Wang X, et al., 2021, Identification and validation
https://doi.org/10.1007/s10585-023-10208-8 of an immune-related prognostic signature and key gene in
15. Kang YJ, Stybayeva G, Hwang SH, 2023, Surgical papillary thyroid carcinoma. Cancer Cell Int, 21(1): 378.
completeness and safety of minimally invasive thyroidectomy https://doi.org/10.1186/s12935-021-02066-9
in patients with thyroid cancer: A network meta-analysis.
Surgery, 173(6): 1381–1390. 26. Xue Y, Li J, Lu X, 2020, A novel immune-related prognostic
signature for thyroid carcinoma. Technol Cancer Res Treat, 19.
https://doi.org/10.1016/j.surg.2023.02.021
https://doi.org/10.1177/1533033820935860
16. Sherman SI, 2003, Thyroid carcinoma. Lancet, 361(9356):
501–511. 27. Ge M, Niu J, Hu P, et al., 2021, A ferroptosis-related
signature robustly predicts clinical outcomes and associates
https://doi.org/10.1016/s0140-6736(03)12488-9 with immune microenvironment for thyroid cancer. Front
17. Gulfidan G, Soylu M, Demirel D, et al., 2022, Systems Med (Lausanne), 8: 637743.
biomarkers for papillary thyroid cancer prognosis and https://doi.org/10.3389/fmed.2021.637743
treatment through multi-omics networks. Arch Biochem
Biophys, 715: 109085. 28. Li Q, Wang P, Sun C, et al., 2019, Integrative analysis of
methylation and transcriptome identified epigenetically
https://doi.org/10.1016/j.abb.2021.109085 regulated lncRNAs with prognostic relevance for thyroid
cancer. Front Bioeng Biotechnol, 7: 439.
18. Patel J, Klopper J, Cottrill EE, 2023, Molecular diagnostics
in the evaluation of thyroid nodules: Current use and https://doi.org/10.3389/fbioe.2019.00439

Volume 2 Issue 3 (2023) 19 https://doi.org/10.36922/gpd.1138